StockData
Neurogene Inc. logo

Neurogene Inc. (NGNE) stock

NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)

Close on Nov 17, 2026Market cap $462.26MP/E –Yield –

Neurogene total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Neurogene

Neurogene has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Neurogene figures

See a number that looks wrong?